Recall of Zimmer Air Dermatome (Air powered surgical skin grafting device)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by Zimmer Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2013-RN-00481-1
  • Event Risk Class
    Class II
  • Event Initiated Date
    2013-05-20
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    Zimmer have received reports of broken planetary gear teeth, which can cause the air dermatome to either not operate or operate intermittently. this may cause a delay or postponement of the surgery or result in a suboptimal retrieval with potential of requiring an additional donor site.
  • Action
    Customers are requested to remove the device from use and arrange with Zimmer Customer Service for a return and repair.

Device

  • Model / Serial
    Zimmer Air Dermatome (Air powered surgical skin grafting device)Part Number: 00-8801-001-00Serial Numbers: 109445, 111058, 1111059, 111067, 111101, 111102, 111122ARTG number: 115929
  • Manufacturer

Manufacturer

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.
  • Source
    DHTGA